VERTEX PHARMACEUTICALS INC

Create Email Alert

Vertex Pharmaceuticals is based out of Boston. Vertex Pharmaceuticals develops and commercializes small molecule drugs for diseases including HIV infection, hepatitis C virus infection, and inflammatory and autoimmune disorders, cancer, pain and bacterial infection.Whalewisdom has at least 5 13D filings, 3 13G filings, and 940 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2009-03-18. The notice included securities offered of Equity

Contact Info

vertex pharmaceuticals inc
50 NORTHERN AVENUE
BOSTON MA    02210
Business Phone: 6173416393
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Global (ex. US) Holdings

A premium subscription (standard or higher) is required to view global (non-US) holdings

Stale Holdings (no activity in past 21-months or sold out)

Source: Refinitiv. Stale holdings data removed after 21-months of inactivity.

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2009-03-18 D BIOTECHNOLOGY Equity 2,397,225 2,397,225 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
JOSHUA S. BOGER subscription required
    EXECUTIVE OFFICER DIRECTOR
MATTHEW W. EMMENS subscription required
    EXECUTIVE OFFICER DIRECTOR
IAN F. SMITH subscription required
    EXECUTIVE OFFICER
KENNETH S. BOGER subscription required
    EXECUTIVE OFFICER
ROGER W. BRIMBLECOMBE subscription required
    DIRECTOR
ERIC K. BRANDT subscription required
    DIRECTOR
STUART J.M. COLLINSON subscription required
    DIRECTOR
EUGENE H. CORDES subscription required
    DIRECTOR
BRUCE I. SACHS subscription required
    DIRECTOR
CHARLES A. SANDERS subscription required
    DIRECTOR
ELAINE S. ULLIAN subscription required
    DIRECTOR
FREDA C. LEWIS-HALL subscription required
    EXECUTIVE OFFICER
KURT C. GRAVES subscription required
    EXECUTIVE OFFICER
RICHARD C. GARRISON subscription required
    EXECUTIVE OFFICER
LISA KELLY-CROSWELL subscription required
    EXECUTIVE OFFICER
AMIT K. SACHDEV subscription required
    EXECUTIVE OFFICER
PAUL M. SILVA subscription required
    EXECUTIVE OFFICER
PETER MUELLER subscription required
    EXECUTIVE OFFICER

Elevate your investments